Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrzej Stefan Krolewski, PH.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
The Role of Carboxypeptidase A in Conferring Susceptibility to Diabetic Nephropathy in Type I Diabetics
Summer, 06/21/99 - 08/21/99

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. DP3DK112177 (KROLEWSKI, ANDRZEJ S) Sep 20, 2016 - Aug 31, 2019
    NIH/NIDDK
    Search for biomarkers to measure progression of diabetic nephropathy in Type 1 diabetes; application of proteomics technologies
    Role: Principal Investigator
  2. R24DK090961 (KING, GEORGE L) Sep 30, 2010 - Aug 31, 2013
    NIH/NIDDK
    Protective Factors Against the Development of Microvascular Complications
    Role: Co-Principal Investigator
  3. R01DK077532 (KROLEWSKI, ANDRZEJ S) Sep 30, 2006 - Aug 31, 2010
    NIH/NIDDK
    Mapping Genes for End-Stage Renal Disease in Type 1 Diabetes
    Role: Principal Investigator
  4. R01DK067638 (KROLEWSKI, ANDRZEJ S) Jul 1, 2004 - Jun 30, 2010
    NIH/NIDDK
    The Urinary Proteome and Renal Function Loss in Diabetes
    Role: Principal Investigator
  5. R01DK058549 (KROLEWSKI, ANDRZEJ S) Dec 1, 2000 - Jun 30, 2013
    NIH/NIDDK
    Mapping genes for proteinuria in type II diabetes
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy. Diabetes Care. 2019 01; 42(1):93-101. PMID: 30455333.
    Citations:    Fields:    
  2. Nabity MB, Polli JW, Vaidya V, Krolewski A, Glaab WE. New Frontiers: Approaches to Understand the Mechanistic Basis of Renal Toxicity. Toxicol Pathol. 2018 12; 46(8):1002-1005. PMID: 30189777.
    Citations:    Fields:    
  3. van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V, Perna A, Rurali E, Marcovecchio ML, Igo RP, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S, Pezzolesi MG, Marre M, Gyorgy B, Hadjadj S, Hiraki LT, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. Diabetes. 2018 07; 67(7):1414-1427. PMID: 29703844.
    Citations:    Fields:    Translation:Humans
  4. Satake E, Pezzolesi MG, Md Dom ZI, Smiles AM, Niewczas MA, Krolewski AS. Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes. Diabetes. 2018 05; 67(5):1013-1023. PMID: 29453204.
    Citations: 2     Fields:    Translation:HumansCells
  5. Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int. 2018 05; 93(5):1198-1206. PMID: 29398132.
    Citations: 1     Fields:    Translation:Humans
  6. Niewczas MA, Krolewski AS. Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390. Diabetes Care. 2017 08; 40(8):e109-e110. PMID: 28733381.
    Citations:    Fields:    Translation:Humans
  7. Yamanouchi M, Skupien J, Niewczas MA, Smiles AM, Doria A, Stanton RC, Galecki AT, Duffin KL, Pullen N, Breyer MD, Bonventre JV, Warram JH, Krolewski AS. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Kidney Int. 2017 07; 92(1):258-266. PMID: 28396115.
    Citations: 1     Fields:    Translation:Humans
  8. Krolewski AS, Skupien J, Rossing P, Warram JH. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017 06; 91(6):1300-1311. PMID: 28366227.
    Citations: 5     Fields:    Translation:Humans
  9. Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care. 2017 Mar; 40(3):383-390. PMID: 28087576.
    Citations: 6     Fields:    Translation:Humans
  10. Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD, Florez JC, Hirschhorn JN, Maxwell AP, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH. The Genetic Landscape of Renal Complications in Type 1 Diabetes. J Am Soc Nephrol. 2017 02; 28(2):557-574. PMID: 27647854.
    Citations: 10     Fields:    Translation:Humans
  11. Skupien J, Warram JH, Smiles AM, Stanton RC, Krolewski AS. Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes. Diabetes Care. 2016 Dec; 39(12):2262-2269. PMID: 27647852.
    Citations: 6     Fields:    Translation:Humans
  12. Nowak N, Skupien J, Niewczas MA, Yamanouchi M, Major M, Croall S, Smiles A, Warram JH, Bonventre JV, Krolewski AS. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int. 2016 Feb; 89(2):459-67. PMID: 26509588; PMCID: PMC4848189.
    Citations: 9     Fields:    Translation:Humans
  13. Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016 Jan; 89(1):226-34. PMID: 26398493.
    Citations: 10     Fields:    Translation:HumansCells
  14. Orlov S, Cherney DZ, Pop-Busui R, Lovblom LE, Ficociello LH, Smiles AM, Warram JH, Krolewski AS, Perkins BA. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1136-44. PMID: 26092828; PMCID: PMC4491301.
    Citations: 5     Fields:    Translation:Humans
  15. Krolewski AS. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015 Jun; 38(6):954-62. PMID: 25998286; PMCID: PMC4439536.
    Citations: 23     Fields:    Translation:Humans
  16. Pezzolesi MG, Satake E, McDonnell KP, Major M, Smiles AM, Krolewski AS. Circulating TGF-ß1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes. Diabetes. 2015 Sep; 64(9):3285-93. PMID: 25931475; PMCID: PMC4542435.
    Citations: 13     Fields:    Translation:Humans
  17. Caramori ML, Kim Y, Goldfine AB, Moore JH, Rich SS, Mychaleckyj JC, Kirkpatrick D, Nickerson H, Krolewski AS, Mauer M. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes. J Clin Endocrinol Metab. 2015 Jun; 100(6):E876-82. PMID: 25871838.
    Citations: 6     Fields:    Translation:HumansCells
  18. Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int. 2015 Apr; 87(4):812-9. PMID: 25272234.
    Citations: 19     Fields:    Translation:Humans
  19. Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, Briskin R, De Jager PL, Ngo TT, Radlinski M, Dear JW, Park KB, Betensky R, Krolewski AS, Bonventre JV. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014 Oct; 25(10):2177-86. PMID: 24904085; PMCID: PMC4178434.
    Citations: 49     Fields:    Translation:HumansAnimals
  20. Skupien J, Warram JH, Smiles A, Galecki A, Stanton RC, Krolewski AS. Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria. J Am Soc Nephrol. 2014 Dec; 25(12):2916-25. PMID: 24904086; PMCID: PMC4243344.
    Citations: 12     Fields:    Translation:Humans
  21. Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS. Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. Diabetes Care. 2014 Sep; 37(9):2601-8. PMID: 24898299; PMCID: PMC4140154.
    Citations: 10     Fields:    Translation:Humans
  22. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. PMID: 24676639; PMCID: PMC4073425.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  23. Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014 May; 85(5):1214-24. PMID: 24429397.
    Citations: 33     Fields:    Translation:Humans
  24. Krolewski AS, Gohda T, Niewczas MA. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes. Clin Exp Nephrol. 2014 Aug; 18(4):571-83. PMID: 24218296; PMCID: PMC4018428.
    Citations: 4     Fields:    Translation:HumansAnimals
  25. Pezzolesi MG, Krolewski AS. Diabetic nephropathy: is ESRD its only heritable phenotype? J Am Soc Nephrol. 2013 Oct; 24(10):1505-7. PMID: 24029425; PMCID: PMC3785288.
    Citations: 2     Fields:    Translation:HumansCells
  26. Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, di Pietro N, Sturma M, Novelli V, Mannino GC, Formoso G, Gervino EV, Hauser TH, Muehlschlegel JD, Niewczas MA, Krolewski AS, Biolo G, Pandolfi A, Rimm E, Sesti G, Trischitta V, Hu F, Doria A. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013 Aug 28; 310(8):821-8. PMID: 23982368; PMCID: PMC3858847.
    Citations: 27     Fields:    Translation:HumansCells
  27. Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014; 37(1):226-34. PMID: 23939543; PMCID: PMC3867993.
    Citations: 53     Fields:    Translation:Humans
  28. Skupien J, Warram JH, Groop PH, Krolewski AS. Cystatin-based estimated GFR versus creatinine-based and creatinine- and cystatin-based estimated GFR for ESRD and mortality risk in diabetes. Am J Kidney Dis. 2013 Jul; 62(1):184-6. PMID: 23684753.
    Citations: 3     Fields:    Translation:Humans
  29. Pezzolesi MG, Jeong J, Smiles AM, Skupien J, Mychaleckyj JC, Rich SS, Warram JH, Krolewski AS. Family-based association analysis confirms the role of the chromosome 9q21.32 locus in the susceptibility of diabetic nephropathy. PLoS One. 2013; 8(3):e60301. PMID: 23555951; PMCID: PMC3612041.
    Citations: 9     Fields:    Translation:HumansCells
  30. Lee JE, Gohda T, Walker WH, Skupien J, Smiles AM, Holak RR, Jeong J, McDonnell KP, Krolewski AS, Niewczas MA. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS One. 2013; 8(3):e58007. PMID: 23526964; PMCID: PMC3603950.
    Citations: 10     Fields:    Translation:Humans
  31. Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS. Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline. PLoS One. 2013; 8(3):e57751. PMID: 23505438; PMCID: PMC3591403.
    Citations: 2     Fields:    Translation:HumansCells
  32. Merchant ML, Niewczas MA, Ficociello LH, Lukenbill JA, Wilkey DW, Li M, Khundmiri SJ, Warram JH, Krolewski AS, Klein JB. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int. 2013 Jun; 83(6):1177-84. PMID: 23466993.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  33. Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, Weil EJ, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ, Werner T, Kretzler M. From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy. Diabetes. 2013 Jul; 62(7):2605-12. PMID: 23434934; PMCID: PMC3712052.
    Citations: 22     Fields:    Translation:HumansCells
  34. Pezzolesi MG, Krolewski AS. The genetic risk of kidney disease in type 2 diabetes. Med Clin North Am. 2013 Jan; 97(1):91-107. PMID: 23290732; PMCID: PMC3539136.
    Citations: 12     Fields:    Translation:Humans
  35. Krolewski AS, Bonventre JV. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol. 2012 Sep; 32(5):407-14. PMID: 23062980; PMCID: PMC3474985.
    Citations: 11     Fields:    Translation:Humans
  36. Krolewski AS, Bonventre JV. High risk of ESRD in type 1 diabetes: call for action: introduction. Semin Nephrol. 2012 Sep; 32(5):405-6. PMID: 23062979.
    Citations: 1     Fields:    Translation:Humans
  37. Krolewski AS, Warram JH, Forsblom C, Smiles AM, Thorn L, Skupien J, Harjutsalo V, Stanton R, Eckfeldt JH, Inker LA, Groop PH. Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care. 2012 Nov; 35(11):2311-6. PMID: 22851596; PMCID: PMC3476893.
    Citations: 20     Fields:    Translation:Humans
  38. Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, Cantarovich D, Stanton R, Krolewski AS. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int. 2012 Sep; 82(5):589-97. PMID: 22622493; PMCID: PMC3425658.
    Citations: 32     Fields:    Translation:Humans
  39. Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS One. 2012; 7(4):e35655. PMID: 22558190; PMCID: PMC3338454.
    Citations: 15     Fields:    Translation:Humans
  40. Gohda T, Walker WH, Wolkow P, Lee JE, Warram JH, Krolewski AS, Niewczas MA. Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes. Am J Physiol Renal Physiol. 2012 Jul 01; 303(1):F157-62. PMID: 22513848; PMCID: PMC3431142.
    Citations: 8     Fields:    Translation:Humans
  41. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):507-15. PMID: 22266663; PMCID: PMC3294310.
    Citations: 111     Fields:    Translation:HumansCells
  42. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):516-24. PMID: 22266664; PMCID: PMC3294299.
    Citations: 91     Fields:    Translation:HumansCells
  43. Doria A, Krolewski AS. Diabetes: Lowering serum uric acid levels to prevent kidney failure. Nat Rev Nephrol. 2011 Aug 02; 7(9):495-6. PMID: 21808278.
    Citations: 4     Fields:    Translation:Humans
  44. Pezzolesi MG, Poznik GD, Skupien J, Smiles AM, Mychaleckyj JC, Rich SS, Warram JH, Krolewski AS. An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. Kidney Int. 2011 Jul; 80(1):105-11. PMID: 21412220; PMCID: PMC3774030.
    Citations: 11     Fields:    Translation:HumansCells
  45. Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol. 2011 Mar; 22(3):545-53. PMID: 21355053; PMCID: PMC3060448.
    Citations: 63     Fields:    Translation:Humans
  46. Kure M, Pezzolesi MG, Poznik GD, Katavetin P, Skupien J, Dunn JS, Mychaleckyj JC, Warram JH, Krolewski AS. Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes. Mol Genet Metab. 2011 May; 103(1):60-5. PMID: 21277817; PMCID: PMC3081941.
    Citations: 4     Fields:    Translation:Humans
  47. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-ß-D-glucosaminidase. Kidney Int. 2011 Feb; 79(4):464-70. PMID: 20980978; PMCID: PMC3033751.
    Citations: 69     Fields:    Translation:Humans
  48. Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010 Nov; 9(11):2424-37. PMID: 20616184; PMCID: PMC2984241.
    Citations: 90     Fields:    Translation:Humans
  49. Liew CW, Bochenski J, Kawamori D, Hu J, Leech CA, Wanic K, Malecki M, Warram JH, Qi L, Krolewski AS, Kulkarni RN. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest. 2010 Aug; 120(8):2876-88. PMID: 20592469; PMCID: PMC2912176.
    Citations: 46     Fields:    Translation:HumansAnimalsCells
  50. Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010 Jun; 33(6):1337-43. PMID: 20332356; PMCID: PMC2875450.
    Citations: 50     Fields:    Translation:Humans
  51. Pezzolesi MG, Skupien J, Mychaleckyj JC, Warram JH, Krolewski AS. Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection. Semin Nephrol. 2010 Mar; 30(2):126-40. PMID: 20347642; PMCID: PMC2847588.
    Citations: 9     Fields:    Translation:HumansAnimals
  52. Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int. 2010 Jan; 77(1):57-64. PMID: 19847154; PMCID: PMC3725722.
    Citations: 84     Fields:    Translation:Humans
  53. Tsaih SW, Pezzolesi MG, Yuan R, Warram JH, Krolewski AS, Korstanje R. Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney Int. 2010 Feb; 77(3):201-10. PMID: 19924099; PMCID: PMC2807478.
    Citations: 20     Fields:    Translation:HumansAnimals
  54. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS, Krolewski AS, Bonner-Weir S, Sharma A, Sale M, Mychaleckyj JC, Kulkarni RN, Doria A. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci U S A. 2009 Aug 25; 106(34):14460-5. PMID: 19667185.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  55. Pezzolesi MG, Katavetin P, Kure M, Poznik GD, Skupien J, Mychaleckyj JC, Rich SS, Warram JH, Krolewski AS. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes. 2009 Nov; 58(11):2698-702. PMID: 19651817; PMCID: PMC2768169.
    Citations: 48     Fields:    Translation:Humans
  56. Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB. Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol. 2009 Sep; 20(9):2065-74. PMID: 19643930; PMCID: PMC2736765.
    Citations: 48     Fields:    Translation:HumansCells
  57. Perkins BA, Aiello LP, Krolewski AS. Diabetes complications and the renin-angiotensin system. N Engl J Med. 2009 Jul 02; 361(1):83-5. PMID: 19571288.
    Citations: 7     Fields:    Translation:Humans
  58. Perkins BA, Krolewski AS. Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens. 2009 May; 18(3):233-40. PMID: 19300247; PMCID: PMC2830878.
    Citations: 12     Fields:    Translation:Humans
  59. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes. 2009 Jun; 58(6):1403-10. PMID: 19252134; PMCID: PMC2682673.
    Citations: 108     Fields:    Translation:Humans
  60. Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, Krolewski AS. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care. 2009 May; 32(5):889-93. PMID: 19196883; PMCID: PMC2671109.
    Citations: 25     Fields:    Translation:Humans
  61. Tsaih S, Pezzolesi MG, Yuan R, Warram JH, Krolewski AS, Korstanje R. Genetic analysis of albuminuria in the aging mouse and concordance with loci for diabetic nephropathy found in a genome-wide association scan. J Am Soc Neph. 2009; Submitted.
  62. Ficociello LH, Rosolowsky ET, Niewczas M, Maselli NJ, Roshan B, Weinberg JM, Aschengrau A, Stanton RC, Doria D, Warram JH, Krolewski AS. Serum Uric Acid and Early Renal Function Decline in Patients with Type 1 Diabetes and Microalbuminuria. Kidney Int. 2009; (accepted for publication).
  63. Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS (senior author), Klein JB. Urinary petidome analysis and early renal function decline in type 1 diabetics with microalbuminuria. J Am Soc Nephrol. 2009; (accepted for publication).
  64. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2009 Jan; 4(1):62-70. PMID: 19073786; PMCID: PMC2615709.
    Citations: 52     Fields:    Translation:HumansCells
  65. Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, Krolewski AS. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract. 2008 Nov 13; 82 Suppl 1:S46-53. PMID: 18849087.
    Citations: 11     Fields:    Translation:Humans
  66. Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies. Diabetes. 2008 Sep; 57(9):2547-51. PMID: 18753673; PMCID: PMC2518509.
    Citations: 17     Fields:    Translation:HumansCells
  67. Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH, Krolewski AS. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes. 2008 Sep; 57(9):2519-26. PMID: 18559660; PMCID: PMC2518505.
    Citations: 17     Fields:    Translation:HumansCells
  68. Ng DP, Nurbaya S, Ye SH, Krolewski AS. An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. Kidney Int. 2008 Aug; 74(4):521-7. PMID: 18496509; PMCID: PMC2756185.
    Citations: 9     Fields:    Translation:HumansCells
  69. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008 May; 3(3):706-13. PMID: 18272826; PMCID: PMC2386694.
    Citations: 41     Fields:    Translation:HumansCells
  70. Ng DP, Nurbaya S, Choo S, Koh D, Chia KS, Krolewski AS. Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes. Nephrol Dial Transplant. 2008 Jul; 23(7):2260-4. PMID: 18263927.
    Citations: 3     Fields:    Translation:Humans
  71. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol. 2008 Apr; 19(4):789-97. PMID: 18256362; PMCID: PMC2390964.
    Citations: 45     Fields:    Translation:Humans
  72. Wanic K, Malecki MT, Klupa T, Warram JH, Sieradzki J, Krolewski AS. Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes. Diabet Med. 2007 Jun; 24(6):650-5. PMID: 17403124.
    Citations: 2     Fields:    Translation:Humans
  73. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol. 2007 May; 2(3):461-9. PMID: 17699452.
    Citations: 21     Fields:    Translation:Humans
  74. Keenan HA, Poznik GD, Varo N, Schneider J, Almasy L, Warram JH, Duggirala R, Schoenbeck U, Krolewski AS, Doria A. Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15. Atherosclerosis. 2008 Feb; 196(2):863-70. PMID: 17343862; PMCID: PMC2335172.
    Citations: 5     Fields:    Translation:HumansCells
  75. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007 Apr; 18(4):1353-61. PMID: 17329575.
    Citations: 121     Fields:    Translation:Humans
  76. Wanic K, Malecki MT, Klupa T, Warram JH, Sieradzki J, Krolewski AS. Lack of association between polymorphisms in the gene encoding protein phosphatase 1B (PTPN1) and risk of type 2 diabetes. Diabetic Med. 2007; 24(6):650-5.
  77. Placha G, Poznik GD, Dunn J, Smiles A, Krolewski B, Glew T, Puppala S, Schneider J, Rogus JJ, Rich SS, Duggirala R, Warram JH, Krolewski AS. A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes. 2006 Dec; 55(12):3358-65. PMID: 17130480.
    Citations: 30     Fields:    Translation:HumansCells
  78. Ng DP, Placha G, Choo S, Chia KS, Warram JH, Krolewski AS. A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes. 2006 Sep; 55(9):2660-3. PMID: 16936219.
    Citations: 11     Fields:    Translation:Humans
  79. Dunn JS, Mlynarski WM, Pezzolesi MG, Borowiec M, Powers C, Krolewski AS, Doria A. Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23. Ann Hum Genet. 2006 Sep; 70(Pt 5):587-93. PMID: 16907705.
    Citations: 6     Fields:    Translation:HumansCells
  80. Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes. 2006 Sep; 55(9):2626-30. PMID: 16936213.
    Citations: 20     Fields:    Translation:Humans
  81. Mueller PW, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol. 2006 Jul; 17(7):1782-90. PMID: 16775037.
    Citations: 48     Fields:    Translation:Humans
  82. Malecki MT, Lebrun P, Pezzolesi M, Warram JH, Krolewski AS, Jhala US. A newly identified mutation in an IPF1 binding site of the insulin gene promoter may predispose to type 2 diabetes mellitus. Diabetologia. 2006 Aug; 49(8):1985-7. PMID: 16741735.
    Citations: 1     Fields:    Translation:HumansCells
  83. Wanic K, Malecki MT, Wolkow PP, Klupa T, Skupien J, Bobrek J, Kozek E, Krolewski AS, Sieradzki J. Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population. Diabetes Metab. 2006 Feb; 32(1):86-8. PMID: 16523192.
    Citations: 4     Fields:    Translation:Humans
  84. Placha G, Krolewski AS. Genetic determinants of diabetic nephropathy in type 2 diabetes. The diabetic kidney. Cortes P and Mogensen CE eds). 2006; 329-50.
  85. Mueller PM, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH. The Genetics of Kidneys in Diabetes (GoKinD) Study: A genetics collection available for identifying the genetic susceptibility factors for diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Neph. 2006; 17(7):1782-90.
  86. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, Walker W, Smiles A, Krolewski B, Fogarty DG, Moczulski D, Araki S, Makita Y, Ng DP, Rogus J, Duggirala R, Rich SS, Warram JH. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int. 2006 Jan; 69(1):129-36. PMID: 16374433.
    Citations: 38     Fields:    Translation:Humans
  87. Poznik GD, Adamska K, Xu X, Krolewski AS, Rogus JJ. A novel framework for sib pair linkage analysis. Am J Hum Genet. 2006 Feb; 78(2):222-30. PMID: 16358216; PMCID: PMC1380231.
    Citations: 3     Fields:    Translation:Humans
  88. Perkins BA, Krolewski AS. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep. 2005 Dec; 5(6):455-63. PMID: 16316598.
    Citations: 14     Fields:    Translation:Humans
  89. Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes. 2005 Nov; 54(11):3331-5. PMID: 16249462.
    Citations: 14     Fields:    Translation:Humans
  90. Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes. 2005 Nov; 54(11):3326-30. PMID: 16249461.
    Citations: 11     Fields:    Translation:Humans
  91. Perkins BA, Nelson RG, Krolewski AS. Cystatin C and the risk of death. N Engl J Med. 2005 Aug 25; 353(8):842-4; author reply 842-4. PMID: 16124125.
    Citations: 5     Fields:    Translation:Humans
  92. Ng DP, Krolewski AS. Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med. 2005 Aug; 5(5):509-25. PMID: 16101480.
    Citations: 14     Fields:    Translation:HumansAnimals
  93. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int. 2005 May; 67(5):1684-91. PMID: 15840014.
    Citations: 46     Fields:    Translation:HumansPHPublic Health
  94. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis. 2005 Apr; 12(2):155-69. PMID: 15822051.
    Citations: 28     Fields:    Translation:Humans
  95. Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005 May; 16(5):1404-12. PMID: 15788478.
    Citations: 102     Fields:    Translation:Humans
  96. Warram JH, Krolewski AS. Epidemiology of diabetes mellitus. Joslin's Diabetes Mellitus. Kahn CR, Weir G, King GL, Jacobson AM, Moses AC, Smith RJ (eds.). 2005; 341-354.
  97. Krolewski AS, Warram JH. Epidemiology of late complications of diabetes. Basis for the development and evaluation of preventive programs. Joslin's Diabetes Mellitus. Kahn CR, Weir G, King GL, Jacobson AM, Moses AC, Smith RJ (eds.). 2005; 795-808.
  98. Kim SH, Ma X, Weremowicz S, Ercolino T, Powers C, Mlynarski W, Bashan KA, Warram JH, Mychaleckyj J, Rich SS, Krolewski AS, Doria A. Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes. 2004 May; 53(5):1375-84. PMID: 15111509.
    Citations: 11     Fields:    Translation:HumansCells
  99. Ng DP, Walker WH, Chia KS, Choo S, Warram JH, Krolewski AS. Scrutiny of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) locus reveals conserved haplotype block structure not associated with diabetic nephropathy. Diabetes. 2004 Mar; 53(3):865-9. PMID: 14988277.
    Citations: 1     Fields:    Translation:HumansCells
  100. Pezzolesi MG, Nam M, Nagase T, Klupa T, Dunn JS, Mlynarski WM, Rich SS, Warram JH, Krolewski AS. Examination of candidate chromosomal regions for type 2 diabetes reveals a susceptibility locus on human chromosome 8p23.1. Diabetes. 2004 Feb; 53(2):486-91. PMID: 14747302.
    Citations: 9     Fields:    Translation:HumansCells
  101. Ng DP, Warram JH, Krolewski AS. To: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428. Diabetologia. 2003 Dec; 46(12):1706. PMID: 14595537.
    Citations: 1     Fields:    Translation:Humans
  102. Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus. J Am Soc Nephrol. 2003 Aug; 14(8):2015-24. PMID: 12874455.
    Citations: 7     Fields:    Translation:HumansCells
  103. Kim SH, Ma X, Klupa T, Powers C, Pezzolesi M, Warram JH, Rich SS, Krolewski AS, Doria A. Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24. Diabetes. 2003 Aug; 52(8):2182-6. PMID: 12882939.
    Citations: 7     Fields:    Translation:HumansCells
  104. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003 Jun 05; 348(23):2285-93. PMID: 12788992.
    Citations: 193     Fields:    Translation:Humans
  105. Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes. Am J Kidney Dis. 2003 Jun; 41(6):1189-94. PMID: 12776270.
    Citations: 3     Fields:    Translation:Humans
  106. Ng DP, Warram JH, Krolewski AS. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis. 2003 Jan; 41(1):22-8. PMID: 12500218.
    Citations: 8     Fields:    Translation:Humans
  107. Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, Malecki MT, Doria A, Rich SS, Krolewski AS. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care. 2002 Dec; 25(12):2292-301. PMID: 12453976.
    Citations: 10     Fields:    Translation:HumansCells
  108. Szabó C, Zanchi A, Komjáti K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002 Nov 19; 106(21):2680-6. PMID: 12438293.
    Citations: 55     Fields:    Translation:HumansCellsCTClinical Trials
  109. Ng DP, Canani L, Araki S, Smiles A, Moczulski D, Warram JH, Krolewski AS. Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes. 2002 Jul; 51(7):2264-9. PMID: 12086959.
    Citations: 13     Fields:    Translation:HumansCells
  110. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes. 2002 Jun; 51(6):1655-62. PMID: 12031950.
    Citations: 15     Fields:    Translation:Humans
  111. Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes. 2002 Apr; 51(4):1188-93. PMID: 11916943.
    Citations: 11     Fields:    Translation:Humans
  112. Antonellis A, Rogus JJ, Canani LH, Makita Y, Pezzolesi MG, Nam M, Ng D, Moczulski D, Warram JH, Krolewski AS. A method for developing high-density SNP maps and its application at the type 1 angiotensin II receptor (AGTR1) locus. Genomics. 2002 Mar; 79(3):326-32. PMID: 11863362.
    Citations: 3     Fields:    Translation:HumansCells
  113. Weijnen CF, Rich SS, Meigs JB, Krolewski AS, Warram JH. Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies. Diabet Med. 2002 Jan; 19(1):41-50. PMID: 11869302.
    Citations: 28     Fields:    Translation:Humans
  114. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes. 2001 Dec; 50(12):2842-9. PMID: 11723069.
    Citations: 29     Fields:    Translation:Humans
  115. Moczulski DK, Rogus JJ, Krolewski AS. Comment to: F. M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44: 602-604. Diabetologia. 2001 Dec; 44(12):2237-8. PMID: 11793027.
    Citations: 1     Fields:    Translation:Humans
  116. Canani LH, Araki S, Warram JH, Krolewski AS. Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107. Diabetologia. 2001 Aug; 44(8):1062-4. PMID: 11484086.
    Citations: 4     Fields:    Translation:Humans
  117. Kim SH, Warram JH, Krolewski AS, Doria A. Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes. J Clin Endocrinol Metab. 2001 May; 86(5):2320-2. PMID: 11344245.
    Citations: 4     Fields:    Translation:Humans
  118. Krolewski AS, Ng DP, Canani LH, Warram JH. Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv Nephrol Necker Hosp. 2001; 31:295-315. PMID: 11692468.
    Citations: 3     Fields:    Translation:Humans
  119. Bektas A, Hughes JN, Warram JH, Krolewski AS, Doria A. Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes. Diabetes. 2001 Jan; 50(1):204-8. PMID: 11147789.
    Citations: 4     Fields:    Translation:HumansCells
  120. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes. 2000 Dec; 49(12):2190-5. PMID: 11118024.
    Citations: 15     Fields:    Translation:Humans
  121. Araki S, Makita Y, Canani L, Ng D, Warram JH, Krolewski AS. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus. Diabetologia. 2000 Dec; 43(12):1540-3. PMID: 11151764.
    Citations: 5     Fields:    Translation:HumansCells
  122. Klupa T, Malecki MT, Pezzolesi M, Ji L, Curtis S, Langefeld CD, Rich SS, Warram JH, Krolewski AS. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes. 2000 Dec; 49(12):2212-6. PMID: 11118028.
    Citations: 25     Fields:    Translation:HumansCells
  123. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes. 2000 Jun; 49(6):1057-63. PMID: 10866060.
    Citations: 10     Fields:    Translation:Humans
  124. Rabinowitz D, Zanchi A, Schaumberg D, Krolewski A. Testing mode of inheritance of a candidate mutation at a quantitative trait locus. Hum Hered. 2000 May-Jun; 50(3):184-8. PMID: 10686498.
    Citations:    Fields:    Translation:Humans
  125. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus. Diabet Med. 2000 Feb; 17(2):111-8. PMID: 10746480.
    Citations: